NF-κB transcriptionally primes NLRP3 and pro-IL-1β, positioning canonical inflammatory signals such as TNFα or TLR ligands to sensitize GBM/TME cells to inflammasome activation. The gene discussed is IL1B; the disease is glioblastoma.